Epidemiology of adult idiopathic inflammatory myopathies in a US managed care plan
… Furst, Amato, and Iorga have received research funding from MedImmune, LLC, and Ms.
Gajria … Iorga and Ms. Gajria had full access to all of the data in the study; they and Dr. Furst take …
Gajria … Iorga and Ms. Gajria had full access to all of the data in the study; they and Dr. Furst take …
[HTML][HTML] Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: real-world …
W März, FW Dippel, K Theobald, K Gorcyca, ŞR Iorga… - Atherosclerosis, 2018 - Elsevier
Background and aims Elevated low-density lipoprotein cholesterol (LDL-C) is a causal risk
factor for cardiovascular (CV) events. European guidelines recommend reducing LDL-C as …
factor for cardiovascular (CV) events. European guidelines recommend reducing LDL-C as …
Epidemiology of systemic sclerosis in a large US managed care population
DE Furst, AW Fernandes, ŞR Iorga, W Greth… - The Journal of …, 2012 - jrheum.org
Objective. To estimate the incidence and prevalence of systemic sclerosis (SSc) in a large
US managed care organization (MCO) database. Methods. Subjects with claims-based …
US managed care organization (MCO) database. Methods. Subjects with claims-based …
[HTML][HTML] A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease
…, E Morris, B Donohue, J Paulose, ŞR Iorga… - Orphanet journal of rare …, 2021 - Springer
Background and purpose Sickle cell disease (SCD) is a collection of rare inherited blood
disorders affecting approximately 100,000 people in the US and 20–25 million people globally. …
disorders affecting approximately 100,000 people in the US and 20–25 million people globally. …
[HTML][HTML] Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: insights from Italian general practice
…, K Gorcyca, ŞR Iorga, AP Maggioni, G Paizis, R Tomic… - Atherosclerosis, 2018 - Elsevier
Background and aims Statin utilization and lipid goal achievement were estimated in a large
sample of Italian patients at high/very-high cardiovascular (CV) risk. Methods Patients aged …
sample of Italian patients at high/very-high cardiovascular (CV) risk. Methods Patients aged …
[HTML][HTML] Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States
AC Klimchak, MY Patel, ŞR Iorga, N Kulkarni… - American journal of …, 2020 - Elsevier
Objective National estimates of atherosclerotic cardiovascular disease (ASCVD) in the
United States (US) are scarce, especially for patients grouped by cardiovascular risk, lipid-…
United States (US) are scarce, especially for patients grouped by cardiovascular risk, lipid-…
Medical costs and health‐care resource use in patients with inflammatory myopathies in an insured population
Introduction: In this study we determined the health‐care costs and resource utilization
associated with idiopathic inflammatory myopathies (IIMs) in a large managed care plan in the …
associated with idiopathic inflammatory myopathies (IIMs) in a large managed care plan in the …
Lipid-lowering therapy and goal achievement in high-risk patients from French general practice
J Ferričres, K Gorcyca, ŞR Iorga, D Ansell… - Clinical Therapeutics, 2018 - Elsevier
… Ferričres, Gorcyca, Iorga, and Steen were involved with the design of the study, interpretation
of data, and critical review of drafts. Dr. Ansell was involved with the design of the study; …
of data, and critical review of drafts. Dr. Ansell was involved with the design of the study; …
Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization
RM Bergenstal, JL Fahrbach, ŞR Iorga, Y Fan… - Endocrine Practice, 2012 - Elsevier
… Iorga MA, PhD 3 , Ying Fan MS 3 , Shonda A. Foster PharmD, MS 2 … Şerban R. Iorga and
Ying Fan are employees of OptumInsight, which received funding to conduct the analysis. …
Ying Fan are employees of OptumInsight, which received funding to conduct the analysis. …
[HTML][HTML] Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based …
…, MK Ito, DG Karalis, HC Huang, ŞR Iorga… - Journal of Clinical …, 2020 - Elsevier
Background A better understanding of patterns in statin utilization and low-density
lipoprotein cholesterol (LDL-C) among patients with atherosclerotic cardiovascular disease (ASCVD) …
lipoprotein cholesterol (LDL-C) among patients with atherosclerotic cardiovascular disease (ASCVD) …